Back to overview
Drug-centric intelligence
Explore compounds with evidence-backed repositioning profiles.
Each drug profile links to verified drug–disease evidence records with PubMed citations, confidence scores, and review status.
CompoundPrimary indicationEvidence recordsProfile
MetforminFDA approved (1995)
Type 2 diabetes mellitus
1 published record
Moderate Evidence
SildenafilFDA approved (1998 ED; 2005 PAH)
Erectile dysfunction; pulmonary arterial hypertension
1 published record
Approved
ThalidomideFDA approved for myeloma (2006); REMS program required
Multiple myeloma; erythema nodosum leprosum
1 published record
Approved
DexamethasoneFDA approved (1958)
Inflammatory and autoimmune conditions; oncology supportive care
1 published record
Strong Repurposing Signal
Sirolimus (Rapamycin)FDA approved (1999 transplant; TSC indications expanded)
Immunosuppression post-transplant; TSC-associated manifestations
1 published record
Approved
AspirinFDA approved
Cardiovascular disease prevention; analgesia
1 published record
Approved
FinasterideFDA approved (BPH 1992; alopecia 1997)
Benign prostatic hyperplasia; androgenetic alopecia
1 published record
Approved
MinoxidilFDA approved
Hypertension (oral); androgenetic alopecia (topical)
1 published record
Approved
HydroxychloroquineFDA approved
Rheumatoid arthritis; systemic lupus erythematosus; malaria prophylaxis
1 published record
Insufficient Evidence